drugset / Trial / NCT02876887

Cocoa to Improve Walking Performance in Peripheral Artery Disease

NCT02876887 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The COCOA-PAD trial will determine whether epicatechin-rich cocoa daily for six months improves walking performance in individuals with peripheral artery disease compared to placebo.

Timeline

Start
2017-01
Primary completion
2019-10-15
Completion
2019-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cocoa Unknown 75 mg —